Research Article
Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System
Table 2
Univariate and multivariate analysis for overall survival of patients in the training set.
| Characteristics | Univariate analysis value | Multivariate analysis | HR (95% CI) | value |
| Age, yrs (<65) | ≥65 | <0.001 | 1.175 (1.102–1.254) | <0.001 |
| Sex (male) | Female | 0.507 | | |
| Location (head) | Body and tail | 0.088 | | | Other | 0.608 | | |
| Year of diagnosis (2004–2009) | 2010–2015 | <0.001 | 0.638 (0.597–0.681) | <0.001 |
| Grade (low grade) | High grade | <0.001 | 1.333 (1.250–1.423) | <0.001 |
| Examined lymph nodes (<15) | ≥15 | <0.001 | 0.800 (0.748–0.856) | <0.001 |
| Extrapancreatic invasion 8th T stage (T1) | <0.001 | 1.199 (1.097–1.310) | <0.001 | T2 | <0.001 | 1.340 (1.200–1.473) | <0.001 | T3 | <0.001 | 1.549 (1.394–1.722) | <0.001 |
| 8th N stage (N0) | N1 | <0.001 | 1.336 (1.235–1.445) | <0.001 | N2 | <0.001 | 1.793 (1.639–1.961) | <0.001 |
| 7th AJCC stage (IA) | IB | <0.001 | | | IIA | <0.001 | | | IIB | <0.001 | | |
|
|
Abbreviations: HR, hazard ratio; CI, confidence interval.
|